Please login to the form below

Not currently logged in
Email:
Password:

Redx Pharma

This page shows the latest Redx Pharma news and features for those working in and with pharma, biotech and healthcare.

AZ sets up joint lab with Cancer Research UK

AZ sets up joint lab with Cancer Research UK

The project is another example of a pharma company getting closer lending technical expertise to publicly funded researchers in return for access to new target discoveries. ... A couple of weeks ago it said it would work with UK biotech Redx Pharma - a

Latest news

  • AZ and Redx collaborate on genetics of cancer AZ and Redx collaborate on genetics of cancer

    AstraZeneca (AZ) is to work with UK biotech Redx Pharma to research the genetic drivers of cancer. ... Research conducted as part of this collaboration will take place both in Alderley Park and at Redx' facility in Liverpool, UK.

  • UK to improve commercial viability of antibiotic research UK to improve commercial viability of antibiotic research

    This has led to such initiatives as the New Drugs for Bad Bugs (ND4BB) programme, involving several pharma companies working together to research new antibiotics as part of the EU-backed ... UK companies trying to develop new antibiotic treatments

  • Redx Pharma to open research centre at AstraZeneca's Alderley Park site Redx Pharma to open research centre at AstraZeneca's Alderley Park site

    Will focus on hard-to-treat infections. Redx Pharma has provided a boost to the hard-hit life sciences industry in Cheshire, UK, announcing its plans to open a research centre ... Clive Morris, VP of R&D at AZ, explained that more companies are expected

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Concept Life Sciences adds to its team Concept Life Sciences adds to its team

    With over 15 years’ experience in the pharmaceutical industry in both biotech and pharma environments, Bingham joins Concept from Rex Pharma, where she held positions as head of research operations and ... He most recently held the role of head of

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Lisa Anson joins the UK biotech as its CEO. Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson. ... Anson, who was previously AstraZeneca’s UK president since 2012, also joins

  • Redx Pharma appoints new chief medical officer Redx Pharma appoints new chief medical officer

    Dr Andrew Saunders joins the UK biotech from Lytix Biopharma. Drug discovery and development group Redx Pharma has appointed Dr Andrew Saunders as its chief medical officer (CMO), a role that ... Ian Ross, chairman of Redx Pharma, said: “Dr Saunders

  • Caldan Therapeutics bolsters senior team Caldan Therapeutics bolsters senior team

    Dr Armstrong brings extensive experience in the pharmaceutical industry to Caldan Therapeutics, and currently also serves as non-executive chairman of Summit plc and RedX Pharma. ... Prior to this, he led Merck's medical science and innovation division,

  • Jane Osbourn to chair BIA board Jane Osbourn to chair BIA board

    Murray of RedX Pharma will be joining.

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics